DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Andre T, Quinaux E, Louvet C et al.
GERCOR. Updated results at 6 year of the GERCOR C96.1 phase III study comparing LV5FU2 to monthly 5FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients.

Journal of Clinical Oncology 2005; . ASCO Annual Meeting Proceedings. 2005
23 (Suppl 16): Abstract 3522

Download Bibliographical Data

Search in: